Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease

Eur Respir J. 2018 Apr 4;51(4):1800084. doi: 10.1183/13993003.00084-2018. Print 2018 Apr.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms*
  • Mediastinum
  • Neoplasm Staging
  • Prospective Studies